3rd Quarter - Report

MAYO CLINIC for MAYO CLINIC

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Opioid Epidemic

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Vice President of the U.S.; SENATE

Health Issues HCR

Affordable Care Act Repeal and Replace; American Health Care Act (H.R. 1628); Telemedicine;

LobbyistCovered position, as disclosed
JENNIFER MALLARD Director, Federal Government Relations

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Vice President of the U.S.; SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office

Bills named: H.R. 1628 (115th)

Medicare/Medicaid MMM

Medicare physicians payments; Medicare hospital payments; Medicare clinical lab payments; Quality Issues; Telemedicine; Drug Pricing

LobbyistCovered position, as disclosed
JENNIFER MALLARD Director, Federal Government Relations

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Vice President of the U.S.; Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH)

Medical/Disease Research/Clinical Labs MED

Lab payments (PAMA); Research Funding; Regulatory Relief

LobbyistCovered position, as disclosed
JENNIFER MALLARD Director, Federal Government Relations

Contacted: SENATE; Vice President of the U.S.; HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS)

Science/Technology SCI

NIH Regulatory Relief; Telemedicine technology; New Diagnostic Tests; Precision Medicine

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Vice President of the U.S.

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.